Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Therapeutic Advances in Hematology
|
February 14, 2022
Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States
Rory M Shallis, Rong Wang, Jan P Bewersdorf, et al.
Blood Advances
|
August 2, 2022
Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea
Rong Wang, Rory M Shallis, Jessica M Stempel, et al.
Leukemia & Lymphoma
|
April 26, 2021
Clinical effectiveness of DNA methyltransferase inhibitors and lenalidomide in older patients with refractory anemia with ring sideroblasts: a population-based study in the United States
Xiaoyi Wang, Amer M Zeidan, Rong Wang, et al.
Plos One
|
May 12, 2021
Overall survival based on oncologist density in the United States: A retrospective cohort study
Sudeep K Siddappa Malleshappa, Smith Giri, Smit Patel, et al.
Leukemia & Lymphoma
|
October 23, 2023
Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia
Scott F Huntington, Enrico de Nigris, Justin Puckett, et al.
Blood Advances
|
November 1, 2021
Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States
Jan Philipp Bewersdorf, Stephanie Prozora, Nikolai A Podoltsev, et al.
Cancers
|
June 26, 2026
Real-World Overall Survival and Time to Next Treatment Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Frontline Setting
Scott F Huntington, Justin T Puckett, Beenish S Manzoor, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 8, 2019
Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's Lymphoma
Scott F Huntington, Jessica R Hoag, Rong Wang, et al.
Leukemia & Lymphoma
|
December 28, 2019
Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study<sup>†</sup>
Amy J Davidoff, Xin Hu, Jan Philipp Bewersdorf, et al.
Cancer
|
June 17, 2017
Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study
Amer M Zeidan, Xin Hu, Jessica B Long, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Therapeutic Advances in Hematology
|
February 14, 2022
Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States
Rory M Shallis, Rong Wang, Jan P Bewersdorf, et al.
Blood Advances
|
August 2, 2022
Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea
Rong Wang, Rory M Shallis, Jessica M Stempel, et al.
Leukemia & Lymphoma
|
April 26, 2021
Clinical effectiveness of DNA methyltransferase inhibitors and lenalidomide in older patients with refractory anemia with ring sideroblasts: a population-based study in the United States
Xiaoyi Wang, Amer M Zeidan, Rong Wang, et al.
Plos One
|
May 12, 2021
Overall survival based on oncologist density in the United States: A retrospective cohort study
Sudeep K Siddappa Malleshappa, Smith Giri, Smit Patel, et al.
Leukemia & Lymphoma
|
October 23, 2023
Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia
Scott F Huntington, Enrico de Nigris, Justin Puckett, et al.
Blood Advances
|
November 1, 2021
Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States
Jan Philipp Bewersdorf, Stephanie Prozora, Nikolai A Podoltsev, et al.
Cancers
|
June 26, 2026
Real-World Overall Survival and Time to Next Treatment Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Frontline Setting
Scott F Huntington, Justin T Puckett, Beenish S Manzoor, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 8, 2019
Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's Lymphoma
Scott F Huntington, Jessica R Hoag, Rong Wang, et al.
Leukemia & Lymphoma
|
December 28, 2019
Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study<sup>†</sup>
Amy J Davidoff, Xin Hu, Jan Philipp Bewersdorf, et al.
Cancer
|
June 17, 2017
Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study
Amer M Zeidan, Xin Hu, Jessica B Long, et al.
Page
of 9